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731JACC Vol. 49, No. 6, 2007 Correspondence
February 13, 2007:729–33hese failed procedures, an additional analysis was stated a priori in
etail in the statistical analysis plan prior to unblinding in which
he lowest (i.e., worst) CFR from the prior ESPRIT (Enhanced
uppression of the Platelet IIb/IIIa Receptor with Integrilin
herapy) substudy (0.55) was imputed to those patients with a
ailed procedure. When patients with a failed procedure were
ncluded in the analysis, no difference was seen between bivalirudin
nd eptifibatide in the primary end point (median of 1.43 for
ivalirudin vs. 1.33 for pooled eptifibatide arms, p  0.13). To
omply with the requests of the reviewers, however, the analysis in
he published report included only patients with a successful PCI
nd does not account for patients with a failed procedure.
Given the potential for clopidogrel pretreatment to confound
he efficacy outcomes in the trial, randomization in the trial was
tratified by clopidogrel pretreatment, and it was prespecified that
he key analyses would be adjusted for clopidogrel pretreatment. In
prespecified analysis, there was a significant interaction term
etween clopidogrel pretreatment and the randomization arm with
espect to the end point of death or myocardial infarction (MI)
p  0.031 for interaction between clopidogrel pretreatment and
andomization arm). Among patients treated with clopidogrel for
6 h before angiography, the risk of death/MI was significantly
ower among patients treated with eptifibatide compared with
ivalirudin (5.0% vs. 10.3%, n  548, p  0.022). In the smaller
ohort of 309 patients treated with clopidogrel for 6 h, no
ignificant difference existed in the incidence of death/MI between
ptifibatide and bivalirudin (9.5% vs. 6.1%, p  0.31). Among
roponin-positive patients treated for 6 h with clopidogrel, the
isk of death/MI was significantly lower among patients treated
ith eptifibatide (4.1%, n  197 vs. 13.2%, n  106, p  0.003).
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n Pigs Not Helpful
wo reports in a 2006 issue of JACC cite studies of the effects of
aser shocks in porcine “models.” Nanthakumar et al. (1) reported
he results of 150 discharges at various body locations in 6 pigs,
oncluding that there may be increased risks for dysrhythmias,
specially under conditions of adrenergic stress. Lakkireddy et al.
2) reported the results of shocks in 5 pigs before and after cocaine
nfusions, using a device designed to mimic the Taser X-26 model.
ocaine increased the ventricular fibrillation (VF) threshold in
hese pigs, suggesting cocaine may be protective for Taser-related
F risk in humans.
Efforts to study the human effects of Taser shocks by substitut-
ng pigs appear to have little rationale or necessity. Important
natomical and electrophysiological differences between humans
nd pigs make pigs poor surrogates for human responses to cardiac
rugs and electrical discharges. Additional confounders include the
se of anesthesia, controlled laboratory conditions, repetitive
hocks in animals smaller than humans, and inability to interview
he subjects about symptoms caused by their Taser exposures.
Nanthakumar et al.’s (1) finding of increased Taser-associated
ysrhythmia risk in pigs contrasts with a 2005 study in healthy human
olunteers (3), and is not supported by a review of many thousands of
aser outcomes in police uses and in human volunteers (4). Lak-
ireddy et al.’s (2) conclusion contradicts the known effects of cocaine
n dysrhythmia risk in humans (5,6).
The effects of Taser shocks in humans may not be completely
nderstood, but the useful information to date is from studies in
umans receiving shocks under various circumstances. Conflicting
nd inconsistent results from studies in pigs and other animals have
uddied rather than clarified the picture. No scientific or ethical
ustification exists for such studies when much species-specific
nformation is available and could be expanded (7).
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lectronic Control
evices and the Clinical Milieu
n a 2006 issue of the Journal, Nanthakumar et al. (1) presented a
tudy of Taser ECDs (electronic control devices) using 6 pigs
veraging 50 kg (110 lb). Research on these devices is important as
hey are rapidly changing the practices of law enforcement in
orth America and the United Kingdom with over 620 uses per
ay. The ECD delivers its short, motor-neuron capturing pulses
hrough a pair of small darts (or barbs) attached by very fine wires.
arts were positioned subcutaneously to maximize current
hrough the heart, in a vector not possible in humans due to the
ifferences in thoracic geometry. Some ventricular capture was
een but no arrhythmias induced during 94 full-strength applica-
ions. This is impressive as swine are more sensitive to electrical
nduction of arrhythmias than are other mammals (2), possibly due
o the transmural penetration of the Purkinje fibers (3).
The researchers then infused epinephrine and delivered 16
CD applications—again in the worst-case position. They had
ne case of ventricular fibrillation (VF) from these 16 applications.
he investigators concluded that these devices may have cardiac
isks. Although we recognize the solid reputations of the research-
rs and the quality review process of JACC, we have concerns about
he applicability of this conclusion to the clinical setting. The first
oncern lies with the implicit assumption that the rhythm with a
olice “in-custody death” is VF. The ECDs are involved in 30% to
2% of in-custody deaths (J. Ho, unpublished data, 2006) (4,5).
owever, studies have not reported a single case in which the
resenting rhythm was VF when an ECD was used. A study of
62 consecutive in-custody deaths found that, whereas there was a
ignificant association of impact weapons with sudden death, the
CDs were never (0 of 50; p  0.001) associated with a sudden
ollapse. This would seem to eliminate electrically induced VF as
he cause of death.
The one anecdote, cited in Nanthakumar et al. (1), of possible
lectrically induced VF was misreported with material omissions
6). A violent subject exhibiting all the signs of excited delirium
as briefly subdued with a short ECD discharge. Paramedics were
resent and found a normal pulse and respiration after the ECD
ischarge. After a 14-min delay, the subject collapsed and probably
ad an ideoventricular rhythm. After an aggressive therapy of 3
efibrillation shocks along with atropine and epinephrine, the
ubject finally had the VF strip shown in the published anecdote.
total of 23 min elapsed between the ECD application and the
ublished VF strip.
Our second concern has to do with the timing of the shocks
ith the epinephrine infusion. The study does not mention any
elay between the time of infusion and the ECD application.
Although perhaps counterintuitive, epinephrine reduces the VF
hreshold only for the first few minutes (7). After that there is a
upratachyphylaxis, and the VF threshold is increased significantly
bove the baseline. This timing is concordant with the clinical
cenario. Typically, an individual exhibits violent agitation with pyperactivity (8) for several minutes, and third parties call for help.
he police require 5 to 15 min to arrive before they can apply any
estraint device. At this point, the adrenergic tone has been
levated for several minutes. An epinephrine infusion minutes
efore an ECD shock would appear to give results opposite of those
een with the clinical scenario.
Finally, we would draw attention to the results of the Cleveland
linic study published in the same issue of the Journal (9). This
tudy used significantly higher exposures (total shock charge of
pproximately 2,000 five-second weapon discharges per pig versus
bout 50 for the Nanthakumar et al. [1]) and also evaluated the risk
f the induction of ventricular arrhythmias. The investigators
ound no induction of arrhythmias except at a high multiple of the
evice output and that cocaine increased this safety margin even
urther. That would appear to be more consistent with the clinical
esults in which no objectively documented VF has occurred in
10,000 police uses of these devices.
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1). We disagree with the notion that experimental models are
ever of any use in understanding and in studying arrhythmias.
ost of the work on mechanisms of fibrillation and defibrillation,
ncluding studies in cardiac arrest, have been conducted in guinea
igs, rats, pigs, and dogs. Readers of JACC are quite aware of the
